The U.S. Department of Health and Human Services Office of Inspector General (OIG) has added a new responsibility—risk assessment oversight—to health care organizations’ compliance committees through its corporate integrity agreements (CIAs).
Several CIAs issued in 2022 include a modified Risk Assessment and Internal Review Process section that states, “The Compliance Committee shall be responsible for implementation and oversight of the risk assessment and internal review process.”[1]
The risk assessment and internal review process, which should be conducted annually, requires organizations to: